Literature DB >> 15596753

A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of clustering.

L Linsell1, S N Cousens, P G Smith, R S G Knight, M Zeidler, G Stewart, R de Silva, T F G Esmonde, H J T Ward, R G Will.   

Abstract

BACKGROUND: The authors investigated whether cases of sporadic Creutzfeldt-Jakob disease (CJD) had lived closer to one another at some time in life than individuals without sporadic CJD. Such a phenomenon would be compatible with some cases resulting from transmission.
METHODS: UK sporadic CJD cases occurring from 1990 to 1998 were identified. Age-, sex- and hospital-matched controls were recruited. Lifetime residential histories were obtained by interview, usually with a proxy respondent. With use of Monte Carlo simulation, the residential proximity of cases during various time periods was compared with that expected in the absence of any clustering, using the information collected on the controls.
RESULTS: Two hundred twenty sporadic CJD disease cases and 220 controls were included. Cases lived closer together than might be expected in the absence of any disease-clustering mechanism. This evidence became stronger as the critical period during which residential proximity was required to have occurred extended further into the past.
CONCLUSIONS: These findings are consistent with some sporadic Creutzfeldt-Jakob disease (CJD) cases resulting from exposure to a common external factor. The rarity of sporadic CJD suggests that repeated point-source outbreaks of infection are more likely to explain our observations than direct case-to-case transmission. Identifying sources of such outbreaks many years after the event will be extremely difficult.

Entities:  

Mesh:

Year:  2004        PMID: 15596753     DOI: 10.1212/01.wnl.0000145844.53251.bc

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Spatial clusters of Creutzfeldt-Jakob disease mortality in Japan between 1995 and 2004.

Authors:  Y Doi; T Yokoyama; M Sakai; Y Nakamura; T Tango; K Takahashi
Journal:  Neuroepidemiology       Date:  2008-04-18       Impact factor: 3.282

2.  Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies.

Authors:  Ignacio Mahillo-Fernandez; Jesús de Pedro-Cuesta; Maria José Bleda; Mabel Cruz; Kåre Mølbak; Henning Laursen; Gerhard Falkenhorst; Pablo Martínez-Martín; Ake Siden
Journal:  Neuroepidemiology       Date:  2008-10-09       Impact factor: 3.282

3.  Management and prevention of human prion diseases.

Authors:  Silvia Graziano; Maurizio Pocchiari
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

4.  The Three Glycotypes in the London Classification System of Sporadic Creutzfeldt-Jakob Disease Differ in Disease Duration.

Authors:  Blair Ney; Dhamidhu Eratne; Victoria Lewis; Luke Ney; Qiao-Xin Li; Christiane Stehmann; Steven Collins; Dennis Velakoulis
Journal:  Mol Neurobiol       Date:  2021-04-26       Impact factor: 5.590

Review 5.  Molecular pathogenesis of sporadic prion diseases in man.

Authors:  Jiri G Safar
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

Review 6.  The expanding universe of prion diseases.

Authors:  Joel C Watts; Aru Balachandran; David Westaway
Journal:  PLoS Pathog       Date:  2006-03       Impact factor: 6.823

7.  Transmission of scrapie prions to primate after an extended silent incubation period.

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Sophie Luccantoni-Freire; Evelyne Correia; Nathalie Lescoutra-Etchegaray; Valérie Durand; Capucine Dehen; Olivier Andreoletti; Cristina Casalone; Juergen A Richt; Justin J Greenlee; Thierry Baron; Sylvie L Benestad; Paul Brown; Jean-Philippe Deslys
Journal:  Sci Rep       Date:  2015-06-30       Impact factor: 4.379

8.  Risk behaviors in a rural community with a known point-source exposure to chronic wasting disease.

Authors:  Ralph M Garruto; Chris Reiber; Marta P Alfonso; Heidi Gastrich; Kelsey Needham; Sarah Sunderman; Sarah Walker; Jennifer Weeks; Nicholas Derosa; Eric Faisst; John Dunn; Kenneth Fanelli; Kenneth Shilkret
Journal:  Environ Health       Date:  2008-06-24       Impact factor: 5.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.